If there is one word dominating my conversations with healthcare leaders this month, it’s impact. For the last two years, the industry has lived in a world of endless AI pilots. We’ve marvelled at LLMs that can summarize a patient’s history and chatbots that can answer basic FAQs. But as we move deeper into 2026, the honeymoon phase of experimentation is ending. According to the latest Deloitte Global Health Care Outlook, the pressure is now on to turn these AI experiments into measurable margin improvements and better patient outcomes.
.webp)
The Rise of the "Agentic" Era
We are currently witnessing a fundamental shift from generative AI to agentic AI. While genAI focused on content, agentic AI focuses on intent. These are systems designed to execute tasks such as scheduling a follow-up, coordinating with a pharmacy, or guiding a patient through a complex pre-op checklist.
However, this new power comes with a warning. The next few years are shaping up to be a critical window for AI regulatory transition in healthcare. If we don't build our own governance frameworks now, we are essentially letting tech vendors decide the ethical and clinical boundaries of our patient interactions. At Invoca, we see this as an opportunity: Governance shouldn't be a "say no to AI" department; it should be the "how-to-scale-AI-safely" department.
You Can’t Build AI Programs on Legacy Foundations
One of the most striking findings recently came from St. Luke’s Health System, which reported a $13,000 increase in reimbursement per clinician by using AI to improve revenue cycle coding and documentation review. This represents a fundamental restructuring of healthcare economics.
Yet, for many, this level of success remains out of reach. Our internal research and recent industry benchmarks show that 58% of organizations are still being held back by legacy infrastructure. We are trying to run 2026 intelligence on 2010 foundations. The impact gap is real: health plans are investing heavily in CX, but they aren't seeing the proportional returns because their data is still trapped in silos. Successful AI rollouts rely on access to solid, first-party data, and that can be difficult when you’re hamstrung by legacy systems and processes.
Privacy as a Brand Promise
There’s no avoiding it; we need to talk about data privacy. In 2026, the best healthcare marketing doesn't feel like marketing—it feels like a partnership. Recent surveys show that 75% of patients are deeply concerned about data privacy. In response, the industry is moving away from hyper-personalization (which can feel invasive) toward contextual relevance.
What does that look like? It means using first-party, HIPAA-compliant data to understand the patient's emotional state. Are they calling in a panic at 2 a.m.? Are they confused by a bill? Using data to meet them with empathy in that specific moment—without making them feel like you’ve been "reading their charts"—is how you build brand loyalty in this new era.
The takeaway for April is clear: don’t get distracted by the next shiny object and start by looking at your infrastructure. Is it ready for Agentic AI? Is it protecting patient trust? If the answer is no, that’s where your 2026 strategy needs to begin.
Get the Healthcare Marketing AI Impact Report to discover how your organization's AI strategy stacks up to industry benchmarks.
